Cardiovascular disease is the leading cause of death in the developed world, and as such
there is a pressing need for treatment options. Cardiac tissue engineering emerged from the …

After nearly 50 years of clinical development, durable mechanical circulatory support (MCS)
devices are widely available for patients with advanced heart failure. The field of circulatory …

Background In current international guidelines, intraaortic balloon counterpulsation is
considered to be a class I treatment for cardiogenic shock complicating acute myocardial …

Acute right ventricular (RV) failure is a frequent and serious clinical challenge in the
intensive care unit. It is usually seen as a consequence of left ventricular failure, pulmonary …

BACKGROUND: In current guidelines, intraaortic balloon pumping (IABP) is considered a
class 1 indication in cardiogenic shock complicating acute myocardial infarction. However …

BACKGROUND Myocarditis is an illness caused by inflammation of heart muscle. 1 Viral
infections are the most common cause. Other causes include bacterial and protozoan …

Patients with advanced heart failure have a dismal prognosis and poor quality of life. Heart
transplantation provides an effective treatment for a subset of these patients. This article …

Advanced heart failure (AdHF) represents a challenging aspect of heart failure patients.
Because of worsening clinical symptoms, high rates of re-hospitalization and mortality, AdHF …

Congestive heart failure (HF) remains a serious burden in the Western World. Despite
advances in pharmacotherapy and resynchronization, many patients have progression to …

Implantable left ventricular assist devices (LVADs) are increasingly being used as a bridge
to transplantation or as destination therapy in patients with end stage heart failure refractory …